CN113142349B - Novel bagged tea for preventing coronavirus pneumonia and preparation method thereof - Google Patents

Novel bagged tea for preventing coronavirus pneumonia and preparation method thereof Download PDF

Info

Publication number
CN113142349B
CN113142349B CN202110342205.8A CN202110342205A CN113142349B CN 113142349 B CN113142349 B CN 113142349B CN 202110342205 A CN202110342205 A CN 202110342205A CN 113142349 B CN113142349 B CN 113142349B
Authority
CN
China
Prior art keywords
parts
tea
teabag
ginseng
mesh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110342205.8A
Other languages
Chinese (zh)
Other versions
CN113142349A (en
Inventor
黄璐琦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN113142349A publication Critical patent/CN113142349A/en
Application granted granted Critical
Publication of CN113142349B publication Critical patent/CN113142349B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23FCOFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00Tea; Tea substitutes; Preparations thereof
    • A23F3/34Tea substitutes, e.g. matè; Extracts or infusions thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532Agastache, e.g. giant hyssop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8967Lilium, e.g. tiger lily or Easter lily
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

The invention relates to a teabag for preventing novel coronavirus pneumonia and a preparation method thereof, wherein the teabag comprises the following components in parts by weight: flos Lonicerae, herba Agastaches, bulbus Lilii, poria, herba Menthae, folium Mori, semen Phaseoli, and Ginseng radix; the preparation method comprises the following specific steps: pulverizing or chopping flos Lonicerae, sieving with 10-mesh and 50-mesh sieves, and collecting powder between 10-mesh and 50-mesh sieves; processing other 7 medicinal materials in the same way, wherein the medicinal materials are calculated according to the weight parts of the prescription: respectively mixing 2-8 parts of honeysuckle, 1-6 parts of patchouli, 2-8 parts of lily, 3-10 parts of poria cocos, 1-6 parts of mint, 1-5 parts of mulberry leaf, 2-8 parts of phaseolus calcaratus and 2-9 parts of ginseng, putting the coarse powder into a tea bag filter bag, and sealing. The traditional Chinese medicine composition disclosed by the invention combines the medicines, not only can promote diuresis and eliminate dampness, eliminate dampness with aromatics and turbid pathogen, clear away heat and toxic materials, disperse wind and heat, moisten lung and tonify deficiency, but also can pertinently relieve discomfort such as fever and headache, chest distress and cough, pharyngalgia and the like, is sweet in taste and aromatic in gas, has the same tea color as tea, does not injure the stomach, and has a very good prevention and health-care value.

Description

Novel bagged tea for preventing coronavirus pneumonia and preparation method thereof
Technical Field
The invention relates to the technical field of health-care tea bag preparation, in particular to a novel coronavirus pneumonia prevention tea bag and a preparation method thereof.
Background
Coronaviruses are a large family of viruses known to cause the common cold and more serious diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). The novel coronavirus is a new strain of coronavirus that has not been previously found in humans. People of all ages may be infected, mainly adults, of which the elderly and infirm and sick seem to be more susceptible, and children and pregnant women are also susceptible to pneumonia infected by the novel coronavirus. After people are infected with coronavirus, common signs comprise respiratory symptoms, fever, cough, shortness of breath, dyspnea and the like. In more severe cases, the infection can lead to pneumonia, severe acute respiratory syndrome, renal failure, and even death.
There is currently no specific treatment for diseases caused by the novel coronavirus. However, many symptoms are treatable and therefore need to be treated according to the clinical condition of the patient. In addition, the adjuvant care of infected persons can be very effective.
The third edition of diagnosis and treatment of pneumonia infected by the national novel coronavirus, NCP, is definitely in the category of epidemic diseases in traditional Chinese medicine, causes epidemic pestilence and is located in the lung, and basic pathogenesis is characterized by dampness, heat, toxicity and stasis. The Tong Xiaolin academy states that the epidemic should be distinguished from pestilence and pestilence, and belongs to the category of cold-dampness (pestilence). Pestilence and pestilence belong to yang disease in nature, the ending is yin impairment, and yin impairment is the main line. The disease is a yin disease, the ending is impairment of yang, and the impairment of yang is the main line. In therapeutic methods, cold and dampness are treated. For pathogenic cold being suppressed by pathogenic dampness, it is used to treat cold by means of pungent-warm exterior-releasing. For damp pathogen, it is fragrant and needs to avoid the filth and transform it into turbid. The epidemic situation shows that the symptoms of most patients are obviously improved after Chinese medicinal intervention treatment. For example, the traditional Chinese medicine composition can quickly improve the symptoms of patients in the aspect of treating mild symptoms, and has obvious improvement on fever reduction, cough reduction, sore throat, extreme inappetence and hypodynamia of the patients. The traditional Chinese medicine improves severe cough, chest distress, coarse breath and fever of severe patients, reduces the conversion of severe patients to critical diseases, and has higher conversion rate to common patients.
At present, chinese medicinal preventive formulas are published in a plurality of regions, for example, the Chinese medicinal preventive formula No. 1: 3g of rhizoma atractylodis, 5g of honeysuckle, 3g of dried orange peel, 2g of reed rhizome, 2g of mulberry leaf and 10g of raw astragalus; the traditional Chinese medicine for preventing the No. 2 prescription: 10g of raw astragalus, 10g of fried bighead atractylodes rhizome, 10g of divaricate saposhnikovia root, 6g of cyrtomium rhizome, 10g of honeysuckle flower, 10g of fortune eupatorium herb and 6g of tangerine peel; the internal prescription for preventing the novel coronavirus pneumonia: 10g of honeysuckle, 15g of reed rhizome, 15g of cogongrass rhizome, 10g of wrinkled gianthyssop herb, 6g of angelica dahurica and 6g of tsaoko amomum fruit. After the decoction is decocted, the decoction is large in amount, the traditional Chinese medicine is thick in taste, bitter and astringent in mouthfeel, the general acceptance degree is not high, and stomach discomfort is easily caused due to the bitter and astringent mouthfeel, and certain stimulation is generated more or less. It is not suitable for long-term administration in terms of taste and comfort.
The application publication No. CN 108452195A tea beverage with antiviral cold resistance for sub-health people comprises rhizoma dioscoreae nipponicae, rhizoma phragmitis, herba lophatheri, folium mori and liquorice, and is suitable for the sub-health people in the early stage of influenza A or B virus. The application publication No. CN109892434A health tea for improving immunity comprises flos Chrysanthemi, flos Osmanthi Fragrantis, herba Menthae, flos Rosae Rugosae, fructus fici, herba Gynostemmatis, radix Codonopsis, stigma Maydis, mori fructus, plumula Nelumbinis, and green tea, and has good antioxidant health promotion function and also can improve immunity of cells. However, the related patents do not have the function of preventing and treating the pneumonia caused by dampness, heat, toxicity and stasis and having health care function.
In view of the above situation, the present patent aims at inventing a tea bag with defense effect against pneumonia caused by 'damp, heat, toxicity and blood stasis' and a preparation method thereof, which is used for preventing novel coronavirus pneumonia, has sweet taste, fragrant smell, tea color like soup, does not injure stomach, and has good prevention and health care value.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a novel bagged tea for preventing coronavirus pneumonia, which is used for preventing the novel coronavirus pneumonia, has sweet taste and aromatic smell, is tea-like in soup color, does not hurt the stomach and has good prevention and health care values.
In order to achieve the purpose, the invention adopts the following technical scheme to realize the purpose:
a teabag for preventing novel coronavirus pneumonia comprises the following components in parts by weight: 2-8 parts of honeysuckle, 1-6 parts of patchouli, 2-8 parts of lily, 3-10 parts of poria cocos, 1-6 parts of mint, 1-5 parts of mulberry leaves, 2-8 parts of phaseolus calcaratus and 2-9 parts of ginseng.
Further, the preparation method of the teabag for preventing the novel coronavirus pneumonia comprises the following steps:
(1) Powdering: respectively crushing or chopping flos Lonicerae, herba Agastaches, bulbus Lilii, poria, herba Menthae, folium Mori, semen Phaseoli, and Ginseng radix, sieving with 10 mesh and 50 mesh sieves, continuously crushing or chopping coarse particles which can not pass through 10 mesh sieve, and collecting powder between 10 mesh and 50 mesh sieves;
(2) Mixing: mixing the coarse powders of flos Lonicerae, herba Agastaches, bulbus Lilii, poria, herba Menthae, folium Mori, semen Phaseoli, and Ginseng radix at a certain ratio;
(3) Packaging: quantitatively loading the coarse powder into a bag tea filter bag in a sterile workshop, and sealing.
Preferably, the bag tea filter bag comprises a non-woven bag, a filter bag made of different materials such as nylon and corn fiber.
The invention has the advantages that:
1. according to the tea bag formula provided by the invention, through compatibility of various different traditional Chinese medicinal materials, the poria cocos and the phaseolus calcaratus are used for playing a main prevention role, the honeysuckle and the ginseng are used for playing a secondary role, the agastache rugosus and the lily are used for playing an auxiliary role, and the synergistic effect of the various medicinal materials has a good effect on the prevention of fever and new crown pneumonia infection, so that the immunity of the organism can be enhanced, and a good prevention and health-care effect is achieved.
2. The tea bag provided by the invention combines various medicines, not only can promote diuresis and eliminate dampness, eliminate turbid pathogen with aromatics, clear away heat and toxic materials, disperse wind and heat, moisten lung and tonify deficiency, but also can pertinently relieve discomfort such as fever and headache, chest distress and cough, pharyngalgia and the like, and has good prevention and health care values.
3. The teabag provided by the invention has good taste: the honeysuckle flower in the raw materials can be used as a medicine and also can be frequently used as tea, and the taste is sweet and cool after being brewed; the mint flavor is cool, and the taste is cool, fragrant, sweet and delicious after drinking; the ginseng is sweet in taste, has sweet ginseng fragrance after being brewed, can promote the production of body fluid, can well bring a sweet-aftertaste effect, and has good aftertaste; the raw materials are compounded and brewed into tea, the tea is fragrant, sweet and cool in taste, smooth and mellow in taste, sweet after taste, and free of bitterness, and is a tea bag with good taste.
4. The raw materials of the tea bag provided by the invention contain the fragrant honeysuckle flower tea instead of tea, so that the tea bag smells fragrant and smells fresh and cool; the mint is cool and has faint scent of plant leaves, and can refresh the mind and refresh the brain when being smelled; the brewed tea has natural and fragrant smell, and has faint scent and pleasant and comfortable feeling. And the mint has the function of preventing halitosis, and after drinking, the breath is fresh and the experience is good.
5. The honeysuckle flower tea bag provided by the invention is used as a medicine, is sweet and fragrant in taste, is sweet and does not damage stomach, so that modern people are praised as traditional Chinese medicine antibiotics by doctors, are health-care cold drinks, and are superior products for health care and disease prevention of modern people; herba Agastaches has effects of warming slightly, resolving dampness, activating spleen and promoting appetite; the lily can protect the stomach because of containing the phosphate and the pectin; the raw materials are matched for use, so that the tea is sweet without damaging the stomach, can also strengthen the spleen and stomach, is suitable for frequent drinking, and is a prevention and treatment tea with high health care value.
6. The teabag provided by the invention is convenient to carry, short in brewing time, simple in procedure, and easy to treat medicine dregs: the product is packaged into an independent small package while preventing and protecting health, is convenient to carry when going out, can be enjoyed at any time and any place, and is simple in design and conforms to the fast-paced life of the modern urban society; when the product is processed, granules which are easier to dissolve are formed, the dissolution rate is high, and compared with other decoction, the product has the advantages of simple procedure, short time and convenient obtaining; when brewing, the tea soup is separated from the medicine bag, and the medicine dregs are easy to be treated.
Detailed Description
In order to make the objects, technical solutions and advantageous effects of the present invention more apparent, the present invention is further described in detail with reference to the following detailed description. It should be understood that the detailed description and specific examples, while indicating the preferred embodiment of the invention, are intended for purposes of illustration only and are not intended to limit the scope of the invention.
The invention provides a teabag for preventing novel coronavirus pneumonia, which comprises the following components in parts by weight: 2-8 parts of honeysuckle, 1-6 parts of patchouli, 2-8 parts of lily, 3-10 parts of poria cocos, 1-6 parts of mint, 1-5 parts of mulberry leaves, 2-8 parts of phaseolus calcaratus and 2-9 parts of ginseng.
According to the formula of the tea bag provided by the invention, the poria cocos and the phaseolus calcaratus are used for playing a main prevention role, the honeysuckle and the ginseng are used for playing a secondary role, the agastache rugosus and the lily are used for playing an auxiliary role, and the synergistic effect of the multiple medicinal materials has good effects on the prevention of fever and neocoronary pneumonia infection, so that the immunity of the organism can be enhanced, and the good prevention and health-care effects are achieved. In general, the tea bag combines various medicines, not only can promote diuresis and eliminate dampness, remove dampness with aromatics and turbid pathogen, clear away heat and toxic materials, disperse wind and heat, moisten lung and tonify deficiency, but also can pertinently relieve discomfort such as fever and headache, chest distress and cough, pharyngalgia and the like, has sweet taste and aromatic smell, has tea-like liquor color, does not hurt the stomach, and has good prevention and health care value.
The invention also provides a preparation method of the teabag for preventing the novel coronavirus pneumonia, which comprises the following steps:
(1) Powdering: respectively crushing or chopping flos Lonicerae, herba Agastaches, bulbus Lilii, poria, herba Menthae, folium Mori, semen Phaseoli, and Ginseng radix, sieving with 10 mesh and 50 mesh sieves, continuously crushing or chopping coarse particles which can not pass through 10 mesh sieve, and collecting powder between 10 mesh and 50 mesh sieves; in order to ensure better water extract content when the medicinal materials are soaked for taking, the medicinal materials need to be properly crushed, but the granularity is too fine, the specific surface area of medicinal powder is too large, the adsorption effect is enhanced, the diffusion is influenced, and the water extract is not easy to dissolve out; therefore, the selection of 10-50 meshes of the medicinal powder is more beneficial to the prevention and treatment and health care effects of the raw materials;
(2) Mixing: mixing the coarse powders of flos Lonicerae, herba Agastaches, bulbus Lilii, poria, herba Menthae, folium Mori, semen Phaseoli, and Ginseng radix at a certain proportion;
(3) And (3) packaging: quantitatively packaging the coarse powder in a bag tea filter bag in a sterile workshop, and sealing. According to the requirements of packaging standards, the filter bag of the teabag can be made of different materials such as non-woven bags, nylon, corn fiber and the like.
Example 1
A teabag for preventing novel coronavirus pneumonia comprises the following components in parts by weight: 2 parts of honeysuckle, 1 part of patchouli, 2 parts of lily, 3 parts of tuckahoe, 1 part of mint, 1 part of mulberry leaf, 2 parts of phaseolus calcaratus and 2 parts of ginseng. The preparation method comprises the following steps:
(1) Powdering: respectively crushing or chopping flos Lonicerae, herba Agastaches, bulbus Lilii, poria, herba Menthae, folium Mori, semen Phaseoli, and Ginseng radix, sieving with 10 mesh and 50 mesh sieves, continuously crushing or chopping coarse particles which can not pass through 10 mesh sieve, and collecting powder between 10 mesh and 50 mesh sieves;
(2) Mixing: mixing the coarse powders of flos Lonicerae, herba Agastaches, bulbus Lilii, poria, herba Menthae, folium Mori, semen Phaseoli, and Ginseng radix at a certain proportion;
(3) Packaging: quantitatively packaging the coarse powder in a bag tea filter bag in a sterile workshop, and sealing.
Example 2
A teabag for preventing novel coronavirus pneumonia comprises the following components in parts by weight: 3 parts of honeysuckle, 4 parts of cablin potchouli herb, 3 parts of lily, 5 parts of tuckahoe, 4 parts of mint, 3 parts of mulberry leaf, 5 parts of red bean and 6 parts of ginseng. The preparation process of the formula tea bag is the same as that of example 1.
Example 3
A teabag for preventing novel coronavirus pneumonia comprises the following components in parts by weight: 8 parts of honeysuckle, 6 parts of cablin potchouli herb, 8 parts of lily, 10 parts of tuckahoe, 6 parts of mint, 5 parts of mulberry leaf, 8 parts of red bean and 9 parts of ginseng. The preparation process of the formula tea bag is the same as that of example 1.
Example 4
A teabag for preventing novel coronavirus pneumonia comprises the following components in parts by weight: 2 parts of honeysuckle, 3 parts of cablin potchouli herb, 2 parts of lily, 3 parts of tuckahoe, 2 parts of mint, 2 parts of mulberry leaf, 2 parts of red bean and 3 parts of ginseng. The preparation process of the formula tea bag is the same as that of example 1.
Example 5
A teabag for preventing novel coronavirus pneumonia comprises the following components in parts by weight: 5 parts of honeysuckle, 5 parts of cablin potchouli herb, 6 parts of lily, 8 parts of tuckahoe, 5 parts of mint, 4 parts of mulberry leaf, 6 parts of red bean and 8 parts of ginseng. The preparation process of the formula tea bag is the same as that of example 1.
Comparative example 1
The teabag comprises the following components in parts by weight: 4 parts of patchouli, 3 parts of lily, 5 parts of tuckahoe, 4 parts of mint, 3 parts of mulberry leaf, 5 parts of phaseolus calcaratus and 6 parts of ginseng. The preparation process of the bagged tea of the formula is the same as that of example 2, and only the honeysuckle is not added.
Comparative example 2
The tea bag comprises the following components in parts by weight: 3 parts of honeysuckle, 4 parts of cablin potchouli herb, 3 parts of lily, 5 parts of tuckahoe, 4 parts of mint, 3 parts of mulberry leaf and 5 parts of phaseolus calcaratus. The tea bag preparation process of the formula is the same as that of example 2, except that ginseng is not added.
Comparative example 3
The teabag comprises the following components in parts by weight: 3 parts of honeysuckle, 3 parts of lily, 5 parts of tuckahoe, 4 parts of mint, 3 parts of mulberry leaf, 5 parts of phaseolus calcaratus and 6 parts of ginseng. The teabag preparation process of this formulation was the same as that of example 2 except that no Agastache rugosa was added.
Comparative example 4
The teabag comprises the following components in parts by weight: 3 parts of honeysuckle, 4 parts of cablin potchouli herb, 5 parts of tuckahoe, 4 parts of mint, 3 parts of mulberry leaf, 5 parts of phaseolus calcaratus and 6 parts of ginseng. The tea bag preparation process of the formula is the same as that of example 2, except that no lily is added.
Comparative example 5
The teabag comprises the following components in parts by weight: 3 parts of honeysuckle, 4 parts of cablin potchouli herb, 3 parts of lily, 4 parts of mint, 3 parts of mulberry leaf, 5 parts of phaseolus calcaratus and 6 parts of ginseng. The tea bag preparation process of the formula is the same as that of example 2, except that no tuckahoe is added.
Comparative example 6
The teabag comprises the following components in parts by weight: 3 parts of honeysuckle, 4 parts of patchouli, 3 parts of lily, 5 parts of tuckahoe, 4 parts of mint, 3 parts of mulberry leaf and 6 parts of ginseng. The tea bag preparation process of the formula is the same as that of example 2, except that no phaseolus calcaratus is added.
Comparative example 7
The tea bag comprises the following components in parts by weight: 3 parts of honeysuckle, 4 parts of patchouli, 3 parts of lily, 4 parts of mint, 3 parts of mulberry leaf and 6 parts of ginseng. The preparation process of the bagged tea of the formula is the same as that of example 2, except that no poria cocos and no phaseolus calcaratus are added.
Comparative example 8
The tea bag comprises the following components in parts by weight: 3 parts of honeysuckle, 4 parts of cablin potchouli herb, 3 parts of lily, 5 parts of tuckahoe, 4 parts of mint, 3 parts of mulberry leaf, 5 parts of red bean and 6 parts of ginseng. The preparation process of the teabag of the formula is the same as that of the example 2, except that the medicinal materials are not crushed, and the medicinal materials are directly mixed and bagged.
Comparative example 9
The tea bag comprises the following components in parts by weight: 3 parts of honeysuckle, 4 parts of cablin potchouli herb, 3 parts of lily, 5 parts of tuckahoe, 4 parts of mint, 3 parts of mulberry leaf, 5 parts of phaseolus calcaratus and 6 parts of ginseng. . The teabag preparation process of the formulation is the same as that of example 2, except that 50 mesh sieve powder is used.
Experimental example 1 health Effect test
(1) Inclusion criteria
a. The age is more than or equal to 18 years and less than or equal to 60 years;
b. defining a rework population;
c. body temperature (axillary temperature) is less than or equal to 37.3 ℃;
d. volunteered in the study and signed an informed consent.
Patients who also met the above 4 items were included in this study.
(2) Exclusion criteria
a. Patients with serious primary diseases such as heart, brain, liver, kidney and hematopoietic system;
b. those with pulmonary cachexia;
c. those with mental, intellectual or language handicaps;
d. pregnant women, lactating women and people with pregnancy requirements in about 6 months;
e. those who are unwilling to accept the traditional Chinese medicine tea drink or have the past history of traditional Chinese medicine allergy;
f. patients diagnosed with COVID-19 and healed.
Patients who met any of the above were excluded.
(3) Grouping and prevention method
Random, blank control, multicenter test design methods were used.
Prevention group: the tea bag with the formula is 2 tea bags for 7 days, 2 bags at a time and 2 times per day.
Blank group: the bagged tea is not tried for 7 days.
Observation indexes are as follows: the physical condition of the subject (mainly fever) was followed for 7 days, and the prophylactic group and the blank group were subjected to nucleic acid detection of new coronary pneumonia after the end of the trial.
(4) Prevention of outcome
The body conditions (χ 2 values =4.234, p-bundle 0.05) were significantly different from those of the nucleic acid test (χ 2 values =4.518, p-bundle 0.05) in the preventive group compared to the blank group, and the results are shown in table 1. The number of people with fever and positive people detected by accounting in the prevention group is obviously lower than that of the blank group, and the tea bag provided by the invention has good effects on the prevention of fever and neocoronary pneumonia infection, can enhance the immunity of the organism, and plays a good role in prevention and health care.
Table 1: comparison of prevention Effect between groups
Figure RE-GDA0003093791100000091
Experimental example 2
The inventors selected 700 patients with pulmonary discomfort, all between 20 and 60 years of age. The patients mainly show symptoms of cough with excessive phlegm, chest distress, short breath, unsmooth breathing and the like. During the test period, all patients stop taking other medicines and health care products, live normally, and take the prevention tea bag of the embodiment twice a day, one bag at a time, and the symptoms are relieved after taking the prevention tea bag for two weeks. The patients were divided into one group per 70 th, and the blank group was not taken, and the tea bags prepared in example 2 and comparative examples 1 to 9 were used. The results of the experiment are shown in table 2:
table 2: symptom-improving application effects of different formulas
Figure RE-GDA0003093791100000092
Figure RE-GDA0003093791100000101
As can be seen from Table 2, the improvement effect was significantly different from that of the blank group except for the control example 7. Example 2 the best results, all patients improved symptoms; the comparison examples 1-9 obviously improved the number of people, and the number of ineffective people was increased; the control examples 5 and 7 have diarrhea adverse reactions. Experimental data show that the control examples 5 and 6 respectively lack poria cocos and phaseolus calcaratus have poor improvement effects, which shows that the poria cocos and the phaseolus calcaratus in the formula play a main prevention role, and compared with the control example 7 which lacks the poria cocos and the phaseolus calcaratus, the control example 7 has the worst improvement effect, which shows that the compatibility and combination of the poria cocos and the phaseolus calcaratus in the formula are particularly critical, the two are lack of one and can not be used, and the poria cocos prevents diarrhea after being taken in the formula; the improvement effect is slightly improved corresponding to the comparison examples 1 and 2 which lack honeysuckle and ginseng respectively, which shows that the honeysuckle and the ginseng play secondary roles in the formula; the improvement effects of the corresponding agastache rugosus and lily control examples 3 and 4 are slightly reduced, which shows that the agastache rugosus and the lily plays an auxiliary role in the prevention of the formula; the improvement effect of the tea bag is poor in comparison example 8 and comparison example 9 in which the raw medicinal materials are directly mixed and packaged, wherein the powder is placed under a 50-mesh screen, and the improvement effect of the product is influenced by the granularity of the medicinal materials.
Experimental example 3 evaluation of taste
The tea bags of example 2 and comparative examples 1, 2 and 6 were placed in 500ml glass cups, respectively, and brewed with 300ml boiling water for 5min, and tasted when the temperature dropped to 35 ± 5 ℃, and the taste and smell of different tea bags were compared and scored, and the results are shown in table 3.
Table 3: taste evaluation results
Figure RE-GDA0003093791100000102
Figure RE-GDA0003093791100000111
Grading standard: the rate is preferably-4, more preferably-3, usually-2, and much less preferably-1.
As can be seen from Table 3, the taste scores of the bagged tea of example 2 are all higher than those of the comparative examples 1, 2 and 6, wherein the honeysuckle is absent in the comparative example 1, and the faint scent taste is absent; in contrast 2, the ginseng lacks of ginseng, the fragrance and the taste of the ginseng cannot be reflected, and the effect of promoting the production of body fluid is weakened, so the fragrance is little, and the aftertaste is sweet and weak; in comparative example 6, the lack of red beans did not sufficiently correct the sweetness, and the overall sweetness was slightly weak. The tea bag prepared by the raw material formula of the invention is proved to have better taste and more delicate fragrance, and is a tea bag with good taste and smell.
EXAMPLE 4 Water soluble substance determination test
The tea bags prepared in the embodiment 2 and the comparative examples 8-9 are put into a 500ml conical flask, added with 300ml of boiling water and soaked for 5 minutes, the water solution is poured out, added with 300ml of boiling water and soaked for 5 minutes again, the solution is filtered, the tea bag residues are taken out and dried at constant temperature, and weighed. The water extract content was calculated and the results are shown in table 4 below.
Table 4: measurement of Water-soluble substance
Figure RE-GDA0003093791100000112
As can be seen from Table 4, the water extract content of the teabag of example 2 is higher than that of the comparative examples 8-9 and 7% -12%, and the water extract content of the comparative example 8 is slightly weaker than that of the example because the raw medicinal materials which are not crushed are dissolved out after being soaked and taken; the water-soluble dissolution rate of the tea bag prepared by the formula is only 13%, and the water-soluble dissolution rate is obviously less than that of each example because the particle size is too fine, the specific surface area of the medicinal powder is too large, the adsorption effect is enhanced, and the diffusion is influenced, so that water-soluble substances are not easy to dissolve out, and the particle size of the powder has influence on the dissolution effect of the water-soluble substances.
The invention is not limited to only that described in the specification and embodiments, and thus additional advantages and modifications will readily occur to those skilled in the art, and it is not intended to be limited to the specific details, representative embodiments, and examples shown herein without departing from the spirit and scope of the general concept as defined by the appended claims and their equivalents.

Claims (3)

1. A teabag for preventing novel coronavirus pneumonia is characterized by comprising the following components in parts by weight: 2-8 parts of honeysuckle, 1-6 parts of patchouli, 2-8 parts of lily, 3-10 parts of poria cocos, 1-6 parts of mint, 1-5 parts of mulberry leaves, 2-8 parts of phaseolus calcaratus and 2-9 parts of ginseng.
2. The preparation method of the teabag for preventing the novel coronavirus pneumonia in claim 1 is characterized by comprising the following specific steps of:
s1, crushing or chopping honeysuckle, sieving the honeysuckle with 10-mesh and 50-mesh sieves at the same time, continuously crushing or chopping coarse particles which cannot pass through the 10-mesh sieve, and taking powder between the 10-mesh and 50-mesh sieves;
s2, processing the cablin potchouli herb, the lily bulb, the poria cocos, the mint, the mulberry leaf, the phaseolus calcaratus and the ginseng respectively according to the method of the S1, weighing corresponding coarse powder according to the weight parts, and mixing the coarse powder and the ginseng uniformly;
and S3, filling the coarse powder into a bag tea filter bag, and sealing the bag tea filter bag to obtain the tea bag.
3. The method for preparing teabag according to claim 2, wherein the material of the teabag is selected from non-woven bag, nylon, and corn fiber.
CN202110342205.8A 2020-04-03 2021-03-30 Novel bagged tea for preventing coronavirus pneumonia and preparation method thereof Active CN113142349B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010260249.1A CN111480718A (en) 2020-04-03 2020-04-03 Novel bagged tea for preventing coronavirus pneumonia and preparation method thereof
CN2020102602491 2020-04-03

Publications (2)

Publication Number Publication Date
CN113142349A CN113142349A (en) 2021-07-23
CN113142349B true CN113142349B (en) 2022-10-14

Family

ID=71794527

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202010260249.1A Pending CN111480718A (en) 2020-04-03 2020-04-03 Novel bagged tea for preventing coronavirus pneumonia and preparation method thereof
CN202110342205.8A Active CN113142349B (en) 2020-04-03 2021-03-30 Novel bagged tea for preventing coronavirus pneumonia and preparation method thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN202010260249.1A Pending CN111480718A (en) 2020-04-03 2020-04-03 Novel bagged tea for preventing coronavirus pneumonia and preparation method thereof

Country Status (1)

Country Link
CN (2) CN111480718A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112516276A (en) * 2020-10-15 2021-03-19 湖北思达康中药科技有限公司 Traditional Chinese medicine for preventing novel coronavirus pneumonia, preparation process thereof and traditional Chinese medicine beverage
CN112494611B (en) * 2020-12-10 2022-05-20 广州采芝林药业有限公司 Antioxidant substitutional tea and preparation method thereof
CN114343037A (en) * 2022-01-04 2022-04-15 吕文亮 Health tea bag for preventing pneumonia and preparation method thereof
CN115919970B (en) * 2023-01-07 2023-05-16 中国中医科学院 Traditional Chinese medicine composition and application thereof in novel coronavirus infection

Also Published As

Publication number Publication date
CN111480718A (en) 2020-08-04
CN113142349A (en) 2021-07-23

Similar Documents

Publication Publication Date Title
CN113142349B (en) Novel bagged tea for preventing coronavirus pneumonia and preparation method thereof
CN1075717C (en) Health-care cold tea
CN102845570B (en) Herbal tea for clearing heat and reducing internal heat and preparation method thereof
CN106343090A (en) Fructus siraitiae, prebiotic and chrysanthemum flower tea instant beverage and preparation method thereof
CN101278692A (en) Clear moistening type cold tea and preparation method thereof
CN103637319A (en) Pear soup beverage and preparation method for same
CN102771607A (en) Herbal tea capable of eliminating excess fire and preparation method of herbal tea
CN107156363A (en) A kind of complex tea with effect of weight reducing and preparation method thereof
Reid A Handbook of Chinese Healing Herbs: An Easy-to-Use Guide to 108 Chinese Medicinal Herbs and Dozens of Prepared Herba l Formulas
CN102805774A (en) Chinese medicinal superfine powder for improving organism immunity of livestock and poultry and preparation method thereof
CN107625828A (en) A kind of health protection tea for auxiliary treatment chronic pharyngitis, preparation method and application
CN116616395A (en) Plant solid beverage for improving respiratory tract immunity and preparation process thereof
CN106562159A (en) Flos lonicerae plant mixed drink and production process thereof
CN111529625A (en) Traditional Chinese medicine formula for preventing re-workers from infecting new coronary pneumonia and tea bag
CN106070904A (en) A kind of loquat and preparation method thereof
CN105994783A (en) Tea beverage capable of losing weight without regaining and preparation method thereof
CN111328899A (en) Orange, cattail and perilla herb substituted tea and preparation method thereof
CN109122974A (en) A kind of pumpkin tea and its preparation process
CN104940739A (en) Traditional Chinese medicine composition for biliary ascariasis treating
CN116473179B (en) Plant beverage for improving respiratory tract immunity and preparation process thereof
CN103704409A (en) Herbal tea and preparation method thereof
CN112494611B (en) Antioxidant substitutional tea and preparation method thereof
CN116059301B (en) Tea drink for preventing influenza and preparation method thereof
CN107854592A (en) A kind of preparation method for the film for treating oral ulcer that can quickly eliminate pain
CN106665966A (en) Herbal tea and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant